Systematic review and meta-analysis: Prevalence and possible causes of vitamin D deficiency and insufficiency in pediatric cancer patients

Clinical Nutrition

Volumn 35, Issue 1, 2016, Pages 95-108

  Revuelta Iniesta, R ^a,b   Rush, R ^a   Paciarotti, I ^a,b   Rhatigan, E B ^c   Brougham, F H M ^d   McKenzie, J M ^a   Wilson, D C ^b  

^a QUEEN MARGARET UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c VICTORIA HOSPITAL   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

25(OH)D status,1,25(OH)D; Pediatric cancer; Prevalence; Vitamin D; Vitamin D deficiency

Indexed keywords

VITAMIN D; PARATHYROID HORMONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; AGE; ARTICLE; BRAIN TUMOR; CANCER PATIENT; CANCER STAGING; CHILD; CHILDHOOD CANCER; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; NONHODGKIN LYMPHOMA; PREVALENCE; SOLID TUMOR; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; DIETARY SUPPLEMENT; FACTUAL DATABASE; META ANALYSIS; NEOPLASM;

ADOLESCENT; CHILD; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; PARATHYROID HORMONE; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84922985021     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.12.023     Document Type: Article

References (47)

1. Herbst R.S., Bajorin D.F., Bleiberg H., Blum D., Hao D., Johnson B.E., et al. Clinical cancer advances 2005: major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol 2006, 24:190-205.
2. Ahmed S.F., Franey C., McDevitt H., Somerville L., Butler S., Galloway P., et al. Recent trends and clinical features of childhood vitamin D deficiency presenting to a children's hospital in glasgow. Arch Dis Child 2011, 96:694-696.
3. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80:1678-1688S.
4. Guide for vitamin D in childhood 2013, Available at:, [accessed January 2014]. http://www.rcpch.ac.uk/vitamin-d.
5. Holick M.F., Binkley N.C., Bischoff-Ferrari H., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
6. Holick M.F. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009, 19:73-78.
7. Pramyothin P., Holick M.F. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol 2012, 28:139-150.
8. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
9. Choudhary A., Chou J., Heller G., Sklar C. Prevalence of vitamin D insufficiency in survivors of childhood cancer. Pediatr Blood Cancer 2013, 60:1237-1239.
10. Duncan C.N., Vrooman L., Apfelbaum E.M., Whitley K., Bechard L., Lehmann L.E. 25-hydroxy vitamin D deficiency following pediatric hematopoietic stem cell transplant. Biol Blood Marrow Transpl 2011, 17:749-753.
11. Atkinson S.A. Vitamin D status and bone biomarkers in childhood cancer. Pediatr Blood Cancer 2008, 50:479-482.
12. Wallace W.H.B., Thompson L., Anderson R.A. Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ 2013, 346:f1190.
13. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
14. Oeffinger K.C., Mertens A.C., Sklar C.A., Kawashima T., Hudson M.M., Meadows A.T., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572-1582.
15. Holick M.F. Vitamin D: extraskeletal health. Endocrinol Metab Clin North Am 2010, 39:381.
16. Huh S.Y., Gordon C.M. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord 2008, 9:161-170.
17. Holick M.F., Chen T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008, 87:1080S-1086S.
18. White P., Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000, 11:320-327.
19. Speeckaert M., Huang G., Delanghe J.R., Taes Y.E.C. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006, 372:33-42.
20. Zhou C., Assem M., Tay J.C., Watkins P.B., Blumberg B., Schuetz E.G., et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006, 116:1703-1712.
21. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009, 62:1006-1012.
22. Arikoski P., Komulainen J., Riikonen P., Voutilainen R., Knip M., Kroger H. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab 1999, 84:3174-3181.
23. Atkinson S.A., Halton J.M., Bradley C., Wu B., Barr R.D. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl 1998, 11:35-39.
24. Bilariki K., Anagnostou E., Masse V., Elie C., Grill J., Valteau-Couanet D., Kalifa C., Doz F., Sainte-Rose C., Zerah M., Mascard E., Mosser F., Ruiz J., Souberbielle J., Eladari D., Brugieres L., Polak M. Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivors. Horm Res Paediatr 2010, 74:319-327.
25. El-Ziny M., Al-Tonbary Y., Salama O.S., Bakr A.A., Al-Marsafawy H., Elsharkawy A.A. Low turnover bone disease in Egyptian children with acute leukemia. Hematology 2005, 10:327-333.
26. El-Ziny M., Al-Tonbary Y., Salama O.S., Bakr A., Al-Marsafawy H., Elsharkawy A.A. Low bone mass in children with malignant lymphoma. Pediatr Hematol Oncol 2007, 24:577-585.
27. Halton J.M., Atkinson S.A., Fraher L., Webber C., Gill G.J., Dawson S., et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. JBMR 1996, 11:1774-1783.
28. Henderson R.C., Madsen C.D., Davis C., Gold S.H. Longitudinal evaluation of bone mineral density in children receiving chemotherapy. Pediatr Hematol Oncol 1998, 20:322-326.
29. Rosen G.P., Beebe K.L., Shaibi G.Q. Vitamin D levels differ by cancer diagnosis and decline over time in survivors of childhood cancer. Pediatr Blood Cancer 2013, 60:949-952.
30. Arikoski P., Kröger H., Riikonen P., Parviainen M., Voutilainen R., Komulainen J. Disturbance in bone turnover in children with a malignancy at completion of chemotherapy. Med Pediatr Oncol 1999, 33:455-461.
31. Atkinson S.A., Fraher L., Gundberg C.M., Andrew M., Pai M., Barr R.D. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 1989, 114:793-800.
32. El-Hajj Fuleihan G., Muwakkit S., Arabi A., Daouk L.E., Ghalayini T., Chaiban J., et al. Predictors of bone loss in childhood hematologic malignancies: a prospective study. Osteoporos Int 2012, 23:665-674.
33. Halton J.M., Atkinson S.A., Fraher L., Webber C.E., Cockshott W.P., Tam C., et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 1995, 126:557-564.
34. Modan-Moses D., Pinhas-Hamiel O., Munitz-Shenkar D., Temam V., Kanety H., Toren A. Vitamin D status in pediatric patients with a history of malignancy. Pediatr Res 2012, 72:620-624.
35. de Schepper J., Hachimi-Idrissi S., Louis O., Maurus R., Otten J. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide. Arch Dis Child 1994, 71:346-348.
36. Frisk P., Arvidson J., Ljunggren O., Gustafsson J. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transpl 2012, 47:657-662.
37. Gunes A.M., Can E., Saglam H., Ilcol Y.O., Baytan B. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. Pediatr Hematol Oncol 2010, 32:e102-e107.
38. Sinha A., Avery P., Turner S., Bailey S., Cheetham T. Vitamin D status in paediatric patients with cancer. Pediatr Blood Cancer 2011, 57:594-598.
39. Wiernikowski J.T., Barr R.D., Webber C., Guo C.Y., Wright M., Atkinson S.A. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study. J Oncol Pharm Pract 2005, 11:51-56.
40. Zerwekh J.E. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008, 87:1087S-1091S.
41. Simmons J.H., Chow E.J., Koehler E., Esbenshade A., Smith L.A., Sanders J., et al. Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant. Pediatr Blood Cancer 2011, 56:1114-1119.
42. Vashi P.G., Trukova K., Lammersfeld C.A., Braun D.P., Gupta D. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J 2010, 9:60.
43. Dietary reference intakes for calcium and vitamin D 2010, National Academy Press, Washington, DC, Available at:, [accessed 30.05.14]. http://www.iom.edu/%7E/media/Files/Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Report%20Brief.pdf.
44. Vitamin D blood levels for Canadians 2013, Canada: Health Statistics Division, Available at:, [accessed 30.05.14]. http://www.statcan.gc.ca/pub/82-624-x/2013001/article/11727-eng.pdf.
45. Rosen C.J., Taylor C.L. Common misconceptions about vitamin D - implications for clinicians. Nat Rev Endocrinol 2013, 9:434-438.
46. Kaste S.C., Qi A., Smith K., Surprise H., Lovorn E., Boyett J., et al. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2014, 61:885-893.
47. El-Rassi R, Baliki, G and Fulheihan El-Hajj, G. Vitamin D in the Middle East and Africa. International Osteoporosis Foundation.